Efficacy of Tolebrutinib in Relapsing Multiple Sclerosis

B lymphocytes and myeloids are the major contributors of inflammation in multiple sclerosis. Tolebrutinib, an oral, CNS-penetrant, is an irreversible inhibitor of Bruton’s tyrosine kinase which is an enzyme expressed on B lymphocytes,